1,970
Views
10
CrossRef citations to date
0
Altmetric
Pharmacoeconomics

The 21st Century Cures Act: pharmacoeconomic boon or bane?

Pages 315-317 | Received 12 Jan 2017, Accepted 12 Jan 2017, Published online: 06 Feb 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Roger Lee Mendoza. (2023) Emergent challenges and opportunities in drug discovery and commercialization. Journal of Medical Economics 26:1, pages 1214-1218.
Read now
Katherine H. Luepke & John F. Mohr$suffix/text()$suffix/text(). (2017) The antibiotic pipeline: reviving research and development and speeding drugs to market. Expert Review of Anti-infective Therapy 15:5, pages 425-433.
Read now

Articles from other publishers (7)

Margaret Martin. (2020) The Ethics of Emergent Health Technologies: Implications of the 21st Century Cures Act for Nursing. Policy, Politics, & Nursing Practice 21:4, pages 195-201.
Crossref
Nadezhda Semjonova. (2020) Economic Tendencies of the European and Latvian Medical Device Market. Economics and Business 34:1, pages 297-310.
Crossref
Sara N. Garcia, Rita C. Guedes & M. Matilde Marques. (2020) Unlocking the Potential of HK2 in Cancer Metabolism and Therapeutics. Current Medicinal Chemistry 26:41, pages 7285-7322.
Crossref
Jan Borysowski, Hans‐Jörg Ehni & Andrzej Górski. (2019) Ethics codes and use of new and innovative drugs. British Journal of Clinical Pharmacology 85:3, pages 501-507.
Crossref
Gyöngyi Vastag, Suzana Apostolov, Biljana Kaurinovic & Ljubica Grbovic. (2018) Applying multivariate methods in the estimation of bioactivity properties of acetamide derivatives. JPC - Journal of Planar Chromatography - Modern TLC 31:6, pages 497-504.
Crossref
Joseph A. Goble. (2018) The Potential Effect of the 21st Century Cures Act on Drug Development. Journal of Managed Care & Specialty Pharmacy 24:7, pages 677-681.
Crossref
Jocelyn Gal, Gérard Milano, Jean-Marc Ferrero, Esma Saâda-Bouzid, Julien Viotti, Sylvie Chabaud, Paul Gougis, Christophe Le Tourneau, Renaud Schiappa, Agnes Paquet & Emmanuel Chamorey. (2017) Optimizing drug development in oncology by clinical trial simulation: Why and how?. Briefings in Bioinformatics.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.